Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antibiotic Resistance Market

Antibiotic Resistance Market Size

  • Report ID: GMI6499
  • Published Date: Aug 2023
  • Report Format: PDF

Antibiotic Resistance Market Size

Antibiotic Resistance Market size is valued to be USD 8.2 billion in 2022 and is projected to grow at CAGR of 5.3% and reach USD 13.6 billion by 2032. Some of the major factors driving the growth of this market are increasing incidence of antibiotic resistant infections, growing need for new antibiotic therapies, increasing investment in antibiotic research and development, and increasing global public health concern and awareness.

 

Antibiotic resistance is an ability of bacteria or other microorganisms to resist the effects of antibiotics that were once effective in treating infections caused by them. This resistance develops when bacteria experience genetic alterations or mutations that enable them to survive and thrive even in the presence of antibiotics, reducing or eliminating the effectiveness of the medications. As a result, infections caused by these resistant bacteria become more difficult to treat, leading to prolonged illness, increased treatment costs, and potentially higher mortality rates.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Antibiotic resistance industry size was USD 8.2 billion in 2022 and will reach USD 13.6 billion by the end of 2032 due to the rising investments in research and development along with the increasing global public health concern and awareness.

The hospital pharmacies distribution channel segment held 54% share of the antibiotic resistance industry in 2022 due to the surging need for ensuring that antibiotics are prescribed properly as per the clinical need, susceptibility data, and guidelines.

North America antibiotic resistance market size may record USD 5.5 billion by 2032 driven by the surging government support and fundings in the region

Some of the prominent antibiotic resistance firms are MELINTA THERAPEUTICS, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, WOCKHARDT, Entasis therapeutics, Paratek Pharmaceuticals, Inc., Seres Therapeutics, AbbVie, Inc., Merck & Co. Inc., and Pfizer, Inc

Antibiotic Resistance Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 369
  • Countries covered: 21
  • Pages: 212
 Download Free Sample